Literature DB >> 6244578

Isolation and characterization of polyoma virus mutants able to develop in embryonal carcinoma cells.

M Vasseur, C Kress, N Montreau, D Blangy.   

Abstract

Embryonal carcinoma (EC) mouse cells have been shown to be resistant to infection by retroviruses and small oncogenic DNA viruses, including simian virus 40 and polyoma. When allowed to differentiate, in vitro or in vivo, EC cells become as susceptible to these viruses as differentiated mouse cell lines are. In order to study the relationships between differentiation of EC cells and viral expression, we have isolated and characterized several polyoma mutants that can express early and late functions in undifferentiated EC cells. These mutants, which arose spontaneously during high-multiplicity infection of PCD3 cells (a differentiated fibroblast-like cell line derived from PCC3 EC cells), were selected on PCC4 cells (undifferentiated EC cells) and twice plaque purified. Restriction enzyme analysis of the DNA from several mutants has shown that they all exhibit an additional sequence located in the Pvu II endonuclease fragment 4, close to the junction between Hpa II endonuclease fragments 3 and 5. The size of the insertion varies from 10 to 50 base pairs. The biological properties, including oncogenicity, transforming ability, host range, and burst size of the mutants so far analyzed are similar to those of wild-type virus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244578      PMCID: PMC348425          DOI: 10.1073/pnas.77.2.1068

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Teratocarcinomas as a model system for the study of embryogenesis and neoplasia.

Authors:  G R Martin
Journal:  Cell       Date:  1975-07       Impact factor: 41.582

2.  Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro.

Authors:  D E Swartzendruber; J M Lehman
Journal:  J Cell Physiol       Date:  1975-04       Impact factor: 6.384

3.  [Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells].

Authors:  H Jakob; T Boon; J Gaillard; J Nicolas; F Jacob
Journal:  Ann Microbiol (Paris)       Date:  1973-10

4.  Cell line derived from Balb-3T3 that is transformed by murine leukaemia virus: a focus assay for leukaemia virus.

Authors:  A J Hackett; S S Sylvester
Journal:  Nat New Biol       Date:  1972-10-11

5.  Location of the origin and terminus of replication in polyoma virus DNA.

Authors:  L V Crawford; A K Robbins; P M Nicklin
Journal:  J Gen Virol       Date:  1974-10       Impact factor: 3.891

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Cell lines derived from teratocarcinomas.

Authors:  J F Nicolas; P Avner; J Gaillard; J L Guenet; H Jakob; F Jacob
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

8.  Topography of polyoma virus messenger RNA molecules.

Authors:  R Kamen; H Shure
Journal:  Cell       Date:  1976-03       Impact factor: 41.582

9.  Localization of gene functions in polyoma virus DNA.

Authors:  J Feunteun; L Sompayrac; M Fluck; T Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  25 in total

1.  Nuclear activity from F9 embryonal carcinoma cells binding specifically to the enhancers of wild-type polyoma virus and PyEC mutant DNAs.

Authors:  F K Fujimura
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

Review 2.  What history tells us XXXV. Enhancers: their existence and characteristics have raised puzzling issues since their discovery.

Authors:  Michel Morange
Journal:  J Biosci       Date:  2014-12       Impact factor: 1.826

3.  Negative transcriptional regulatory element that functions in embryonal carcinoma cells.

Authors:  K Ariizumi; H Takahashi; M Nakamura; H Ariga
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

4.  Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells.

Authors:  F Hilberg; C Stocking; W Ostertag; M Grez
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Retroviral vector gene expression in F9 embryonal carcinoma cells.

Authors:  E Linney; S D Neill; D S Prestridge
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.

Authors:  B Wasylyk; J L Imler; B Chatton; C Schatz; C Wasylyk
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  T-antigen-independent replication of polyomavirus DNA in murine embryonal carcinoma cells.

Authors:  L Dandolo; J Aghion; D Blangy
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

8.  Deletions of N-terminal sequences of polyoma virus T-antigens reduce but do not abolish transformation of rat fibroblasts.

Authors:  M Katinka; M Yaniv
Journal:  Mol Cell Biol       Date:  1982-10       Impact factor: 4.272

9.  Physical and biological features of polyoma virus mutants able to infect embryonal carcinoma cell lines.

Authors:  M Vasseur; M Katinka; P Herbomel; M Yaniv; D Blangy
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

10.  Cell-type specific activation of the polyomavirus F9-1 regulatory region in transgenic mice.

Authors:  A Neubauer; M P Manitz; M Napirei; B Krippl
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.